Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Armata Pharmaceuticals, Inc. (APHB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2023 |
SC 13D/A
| Innoviva, Inc. reports a 85.3% stake in ARMATA PHARMACEUTICALS, INC. |
| 01/10/2023 |
SC 13D/A
| Innoviva, Inc. reports a 85.3% stake in ARMATA PHARMACEUTICALS, INC. |
| 04/01/2022 |
SC 13D/A
| Innoviva, Inc. reports a 80.1% stake in ARMATA PHARMACEUTICALS, INC. |
| 02/11/2022 |
SC 13D/A
| Innoviva, Inc. reports a 76.7% stake in ARMATA PHARMACEUTICALS, INC. |
| 11/01/2021 |
SC 13D/A
| Innoviva, Inc. reports a 73.8% stake in ARMATA PHARMACEUTICALS, INC. |
| 04/05/2021 |
SC 13D/A
| Innoviva, Inc. has filed a Schedule 13D for ARMATA PHARMACEUTICALS, INC. |
| 03/17/2021 |
SC 13D/A
| Innoviva, Inc. reports a 74.7% stake in ARMATA PHARMACEUTICALS, INC. |
| 01/27/2021 |
SC 13D/A
| Innoviva, Inc. reports a 68% stake in ARMATA PHARMACEUTICALS, INC. |
| 03/31/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/30/2016 |
SC 13D/A
| KIRK RANDAL J reports a 1.1% stake in AMPLIPHI BIOSCIENCES CORPORATION |
| 11/16/2016 |
SC 13D/A
| KIRK RANDAL J has filed a Schedule 13D for AMPLIPHI BIOSCIENCES CORPORATION |
| 04/15/2016 |
SC 13D/A
| KIRK RANDAL J has filed a Schedule 13D for AMPLIPHI BIOSCIENCES CORPORATION |
| 10/09/2009 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|